News

The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...
The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...
Panelists discuss how exciting ongoing research efforts are expanding similar gene therapy technologies to other muscular ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
Candida, a type of fungus, can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, ...
A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel. There were statistically significant ...
Candida, a type of fungus, which can spread throughout the body via the bloodstream, leading to organ damage and sepsis.
Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...
GSK’s antisense-based drug for chronic hepatitis B, bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval.
Look inside a brain cell with Huntington's disease or ALS and you are likely to find RNA clumped together. These solid-like clusters, thought to be irreversible, can act as sponges that soak up ...
LCGC International interviewed Professor Torgny Fornstedt, Professor in Analytical Chemistry & Leader of the Fundamental ...
Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...